Legend Biotech (LEGN) Misses Q4 EPS by 6c

Legend Biotech (NASDAQ: LEGN) reported Q4 EPS of ($0.40), $0.06 worse than the analyst estimate of ($0.34). Revenue for the quarter came in at $79.46 million versus the consensus estimate of $94.07 million.

For earnings history and earnings-related data on Legend Biotech (LEGN) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Korn Ferry (KFY) Tops Q4 EPS by 2c, Beats on Revenue; Offers Q1 Guidance
• Worthington Industries (WOR) Misses Q4 EPS by 9c